Most Read Articles
4 days ago
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Tristan Manalac, 3 days ago
The coronavirus disease 2019 (COVID-19) appears to be more dangerous among cancer patients, who tend suffer more severe complications and faster disease progression, according to a new study.
Roshini Claire Anthony, 2 days ago

Among patients with nonvalvular atrial fibrillation (AF), treatment with apixaban was associated with a lower rate of ischaemic stroke, systemic embolism, and major bleeding compared with rivaroxaban, according to a large study assessing patients in routine care.

21 hours ago
Exposure to sunlight appears to increase the risk of vulvovaginal candidiasis (VVC) development, reveals a recent study in an African population.

Fish oil beneficial against psoriasis

09 Mar 2020

The use of fish oil and its components may yield favourable effects on psoriasis and its comorbidities, namely obesity, cardiovascular disease and metabolic disease, when combined with conventional treatments, as reported in a recent study.

Researchers performed a quantitative systematic review and searched multiple online databases for studies evaluating the efficacy and safety of fish oil and omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in the treatment of psoriasis. They also conducted a meta-analysis to assess the effects of the said intervention for managing comorbidities.

The search yielded 75 studies, of which 18 randomized controlled trials involving 927 participants met inclusion criteria. Pooled data showed that the use of fish oil or ω-3 PUFAs alone had a null effect on the Psoriasis Area and Severity Index (PASI) score (p=0.47), lesion area (p=0.34) or pruritus (p=0.62).

However, when used in addition to conventional treatments, fish oil or ω-3 PUFAs conferred reductions in PASI score (mean difference [MD], −3.92, 95 percent confidence interval [CI], −6.15 to −1.69; p=0.0006) and lesion area (MD, −30.00, 95 percent CI, −33.82 to −26.18; p<0.0001).

Subgroup analysis showed no significant differences in adverse events between groups that received fish oil (risk ratio [RR], 4.45, 95 percent CI, 0.52–38.16; p=0.17) or ω-3 PUFAs (RR, 1.41, 95 percent CI, 0.53–3.74; p=0.49) and the control.

Finally, fish oil or ω-3 PUFAs produced improvements in certain risk factors for obesity, cardiovascular disease and metabolic disease in psoriatic patients, as well as regulated several inflammatory mediators.

Editor's Recommendations
Most Read Articles
4 days ago
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Tristan Manalac, 3 days ago
The coronavirus disease 2019 (COVID-19) appears to be more dangerous among cancer patients, who tend suffer more severe complications and faster disease progression, according to a new study.
Roshini Claire Anthony, 2 days ago

Among patients with nonvalvular atrial fibrillation (AF), treatment with apixaban was associated with a lower rate of ischaemic stroke, systemic embolism, and major bleeding compared with rivaroxaban, according to a large study assessing patients in routine care.

21 hours ago
Exposure to sunlight appears to increase the risk of vulvovaginal candidiasis (VVC) development, reveals a recent study in an African population.